(EMAILWIRE.COM, July 10, 2018 ) The global superdisintegrants market is expected to reach USD 416.5 Million by 2021 from USD 286.8 Million in 2016, at a CAGR of 7.8% during the forecast period of 2016 to 2021. Growing generic drugs market, growing population of geriatric and paediatric patients, and emergence of new superdisintegrants for the pharmaceutical industry are factors driving the growth of the market. However, factors such as declining R&D expenditures in the development of new superdisintegrants may restrain the growth of this market during the forecast period.

Browse 135 market data Tables with 42 Figures spread through 174 Pages and in-depth TOC on "Superdisintegrants Market"

http://www.marketsandmarkets.com/Market-Reports/superdisintegrants-market-198068672.html

Early buyers will receive 10% customization on reports.

The report analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

This report studied the global superdisintegrants market during the forecast period of 2016 to 2021. The global superdisintegrants market is expected to grow at a CAGR of 7.8% during the forecast period, to reach USD 416.5 Million by 2021. Growth in this market is attributed to factors such as growing population of geriatric and pediatric patients, the growing generic drugs market, and emergence of new superdisintegrants for the pharmaceutical industry. However, factors such as declining R&D expenditures in the development of new superdisintegrants may hinder the growth of this market to a certain extent.

The global superdisintegrants market is segmented by product type, application, therapeutic area, and geography. This report also discusses the key drivers, restraints, opportunities, and challenges for this market. On the basis of product type, the market is primarily segmented into natural superdisintegrants, synthetic superdisintegrants, and others. The synthetic superdisintegrants market is further sub-segmented into modified starch, crospovidone, modified cellulose, ion exchange resins, and calcium silicates. On the other hand, the market based on application is segmented into tablets and capsules. The market by therapeutic area is segmented into gastrointestinal diseases, neurological diseases, oncology, infectious diseases, cardiovascular diseases, haematological diseases, and inflammatory diseases.

In 2015, the synthetic superdisintegrant market segment accounted for the largest share of the global superdisintegrants market. This is majorly attributed to the widespread use of excipients such as sodium starch glycolate, and crospovidone in orally and fast disintegrating tablets. Rising incidences of cardiovascular diseases, neurological diseases, and other related diseases are further expected to drive the demand of fast disintegrating tablets, in-turn driving demand of superdisintegrants during the forecast period.

On the basis of region, the superdisintegrants market is broadly segmented into North America, Europe, Asia-Pacific, and Rest of the World. Increasing investments in the development of novel oral dosage forms and constant efforts dedicated towards providing superior quality and compliant products in the market space are major factors that are expected to drive the growth of the market share for superdisintegrants in North America and Europe. However, Asia-Pacific region is expected to grow at the highest CAGR, owing to increasing healthcare spending, growing health awareness, rising healthcare infrastructure and increasing outsourcing of excipient manufacturing to Asian countries, such as India and China.

Talk to our Experts:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=198068672

Some of the major players operating in the global superdisintegrants market include Ashland, Inc. (U.S.), BASF SE (Germany), FMC Corporation (U.S.), JRS Pharma (Germany), DFE Pharma (Germany), Roquette (France), The Dow Chemical Company (U.S.), Asahi Kasei Corporation (Japan), Nippon Soda Co., Ltd. (Japan), and Huber Corporation (U.S.).

Browse Related Reports:

Pharmaceutical Excipients Market by Products (Organic chemicals, Inorganic Chemicals), Functionality (Fillers, Binders, Lubricants, Preservatives), & by Route of Administration (Oral, Topical, Parenteral, Others) - Global Forecast to 2019

http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html

Active Pharmaceutical Ingredient Market by type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Therapy (Oncology, diabetes, Orthopedic, CNS, Nephrology, Ophthalmology) - Global Forecast to 2020

http://www.marketsandmarkets.com/Market-Reports/API-Market-263.html

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com